Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use

Cannabidiol (CBD) is ubiquitous in state-based medical cannabis programs and consumer products for complementary health or recreational use. CBD has intrinsic pharmacologic effects and associated adverse drug events (ADEs) along with the potential for pharmacokinetic and pharmacodynamic drug–drug in...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Joshua D., Winterstein, Almut G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678684/
https://www.ncbi.nlm.nih.gov/pubmed/31288397
http://dx.doi.org/10.3390/jcm8070989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678684/
https://www.ncbi.nlm.nih.gov/pubmed/31288397
http://dx.doi.org/10.3390/jcm8070989

Ejemplares similares